Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Glucagon on Hepatic Metabolism

NCT05500586 is registered in ClinicalTrials.gov with Adrian Vella as lead sponsor.

NCT NCT05500586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05500586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Glucagon on Hepatic Metabolism
Lead sponsor
Adrian Vella
Phase
Phase 1/2
Overall status
Completed
Start date
October 20, 2022
Completion date
March 31, 2026
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld, obesity, type2diabetes